BEHAVIORAL · Unmapped registry intervention
Early Detection (ED)
Find medicine records ·
Find other trials using this name
Clinical trial
STEP-ED: Reducing Duration of Untreated Psychosis and Its Impact in the U.S.
NCT02069925
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
BEHAVIORAL · Unmapped registry intervention
Usual Detection
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedSTEP-ED: Reducing Duration of Untreated Psychosis and Its Impact in the U.S.
Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Psychosisverified · MONDO: psychotic disorder
Schizophreniaverified · MONDO: schizophrenia
Interventions
Early Detection (ED)BEHAVIORAL
Usual DetectionBEHAVIORAL
Sponsors & collaborators
Yale Universitylead sponsor
Harvard Universitycollaborator
National Institute of Mental Health (NIMH)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02069925 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.